BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6683431)

  • 1. Perfused rat hindlegs. A model to study plasminogen activator release.
    Emeis JJ
    Thromb Res; 1983 May; 30(3):195-203. PubMed ID: 6683431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-type plasminogen activator release in response to epinephrine in perfused rat hindlegs.
    Zhu GJ; Abbadini M; Donati MB; Mussoni L
    Am J Physiol; 1989 Feb; 256(2 Pt 2):H404-10. PubMed ID: 2537033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pentoxifylline (Trental) and two analogues, BL 194 and HWA 448, on the release of plasminogen activators and von Willebrand factor in rats.
    Tranquille N; Emeis JJ
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):35-42. PubMed ID: 1719289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dilazep on fibrinolytic system in animals. II. Enhancing effect of dilazep on plasminogen activator release in the isolated perfused pig ear.
    Nakajima K
    J Pharmacobiodyn; 1982 May; 5(5):363-9. PubMed ID: 6889645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dermatan sulphate induces plasminogen activator release in the perfused rat hindquarters.
    Abbadini M; Zhu GJ; Maggi A; Pangrazzi J; Donati MB; Mussoni L
    Blood; 1987 Dec; 70(6):1858-60. PubMed ID: 3676516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein synthesis inhibition by cycloheximide does not affect the acute release of tissue-type plasminogen activator.
    Tranquille N; Emeis JJ
    Thromb Haemost; 1989 Jun; 61(3):442-7. PubMed ID: 2508256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activator content in heart tissue and perfusate under various experimental conditions.
    Lyutova LV; Andreenko GV; Perova EV; Malchikova LS
    Cor Vasa; 1983; 25(3):206-12. PubMed ID: 6684535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PAF-acether-induced release of tissue-type plasminogen activator from vessel walls.
    Emeis JJ; Kluft C
    Blood; 1985 Jul; 66(1):86-91. PubMed ID: 3924144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MD-805 on plasminogen activator release by thrombin from isolated perfused dog leg.
    Hijikata-Okunomiya A; Kitaguchi H; Hirata M
    Thromb Res; 1987 Mar; 45(5):699-702. PubMed ID: 3590096
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental studies of the liberation of plasminogen activator by DDAVP].
    Jablonowski C; Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):567-74. PubMed ID: 6083928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological observations of plasminogen activator release caused by vasoactive agents in isolated perfused pig ears.
    Nakajima K
    Thromb Res; 1983 Jan; 29(2):163-74. PubMed ID: 6189238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The simultaneous acute release of tissue-type plasminogen activator and von Willebrand factor in the perfused rat hindleg region.
    Tranquille N; Emeis JJ
    Thromb Haemost; 1990 Jun; 63(3):454-8. PubMed ID: 2119527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system.
    Tappy L; Hauert J; Bachmann F
    Thromb Res; 1984 Jan; 33(2):117-24. PubMed ID: 6538346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model system for the in vivo determination of the thrombolytic effect of plasminogen activators.
    Scheu JD; Jing SL; Bruckner-Kardoss E; Gargan PE; Pollard M
    Thromb Res; 1988 Aug; 51(4):391-402. PubMed ID: 3187963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced vascular plasminogen activator (t-PA) release by epinephrine in aged rats.
    Iacoviello L; D'Adamo MC; De Curtis A; Buczko W; Donati MB
    Thromb Haemost; 1995 May; 73(5):841-4. PubMed ID: 7482413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aspirin on the fibrinolytic response in perfused rat hindquarters.
    Iacoviello L; De Curtis A; Amore C; D'Adamo MC; Buczko W; de Gaetano G; Donati MB
    Eur J Pharmacol; 1992 Dec; 229(1):39-44. PubMed ID: 1473562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator release in vivo in response to vasoactive agents.
    Smith D; Gilbert M; Owen WG
    Blood; 1985 Oct; 66(4):835-9. PubMed ID: 3929859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of plasminogen activator by batroxobin.
    Klöcking HP; Hoffmann A; Markwardt F
    Haemostasis; 1987; 17(4):235-7. PubMed ID: 3305231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
    Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
    Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
    Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.